BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 6611355)

  • 1. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.
    Lemire JM; Adams JS; Sakai R; Jordan SC
    J Clin Invest; 1984 Aug; 74(2):657-61. PubMed ID: 6611355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro.
    Lemire JM; Adams JS; Kermani-Arab V; Bakke AC; Sakai R; Jordan SC
    J Immunol; 1985 May; 134(5):3032-5. PubMed ID: 3156926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3-mediated inhibition of human B cell differentiation.
    Chen WC; Vayuvegula B; Gupta S
    Clin Exp Immunol; 1987 Sep; 69(3):639-46. PubMed ID: 3117462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1 alpha,25-Dihydroxyvitamin D3 (calcitriol) stimulates proliferation of human circulating monocytes in vitro.
    Ohta M; Okabe T; Ozawa K; Urabe A; Takaku F
    FEBS Lett; 1985 Jun; 185(1):9-13. PubMed ID: 3838944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of vitamin D3 metabolites on the production of interleukins 1,2 and 3.
    Hodler B; Evêquoz V; Trechsel U; Fleisch H; Stadler B
    Immunobiology; 1985 Nov; 170(4):256-69. PubMed ID: 3002965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells.
    Iho S; Takahashi T; Kura F; Sugiyama H; Hoshino T
    J Immunol; 1986 Jun; 136(12):4427-31. PubMed ID: 3519769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of monocytes in the suppression of PHA-induced proliferation and IL 2 production of human mononuclear cells by 1,25-dihydroxyvitamin D3.
    Iho S; Kura F; Sugiyama H; Takahashi T; Hoshino T
    Immunol Lett; 1985; 11(5-6):331-6. PubMed ID: 3879241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1 alpha,25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: an analysis using serum-free culture conditions.
    Shiozawa K; Shiozawa S; Shimizu S; Fujita T
    Immunology; 1985 Sep; 56(1):161-7. PubMed ID: 3876273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1,25-dihydroxyvitamin D3 on the immunocompetent cells.
    Hoshino T; Iho S; Kura F
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):167-73. PubMed ID: 3487016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture.
    Hale LV; Kemick ML; Wuthier RE
    J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
    Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
    Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes.
    Kanatani M; Sugimoto T; Fukase M; Chihara K
    Biochem Biophys Res Commun; 1993 Jan; 190(2):529-35. PubMed ID: 8427595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3.
    Tsoukas CD; Watry D; Escobar SS; Provvedini DM; Dinarello CA; Hustmyer FG; Manolagas SC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):127-33. PubMed ID: 2525134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells.
    Müller K; Bendtzen K
    Autoimmunity; 1992; 14(1):37-43. PubMed ID: 1299346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous interleukin-2 does not reverse the immunoinhibitory effects of 1,25-dihydroxyvitamin D3 on human peripheral blood lymphocyte immunoglobulin production.
    Jordan SC; Lemire JM; Sakai RS; Toyoda M; Adams JS
    Mol Immunol; 1990 Jan; 27(1):95-100. PubMed ID: 1969110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytes. A mechanism which partially accounts for the antiproliferative effect of 1,25(OH)2D3 on lymphocytes.
    Koren R; Ravid A; Rotem C; Shohami E; Liberman UA; Novogrodsky A
    FEBS Lett; 1986 Sep; 205(1):113-6. PubMed ID: 3462028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes.
    Provvedini DM; Manolagas SC
    J Clin Endocrinol Metab; 1989 Apr; 68(4):774-9. PubMed ID: 2564005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of monocytes and T cells in 1,25-dihydroxyvitamin D3 mediated inhibition of B cell function in vitro.
    Müller K; Heilmann C; Poulsen LK; Barington T; Bendtzen K
    Immunopharmacology; 1991; 21(2):121-8. PubMed ID: 1880018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 acts directly on human lymphocytes and interferes with the cellular response to interleukin-2.
    Koren R; Liberman UA; Maron L; Novogrodsky A; Ravid A
    Immunopharmacology; 1989; 18(3):187-94. PubMed ID: 2606649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.
    Koren R; Ravid A; Liberman UA; Hochberg Z; Weisman Y; Novogrodsky A
    J Clin Invest; 1985 Nov; 76(5):2012-5. PubMed ID: 2997300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.